5 news items
Liquidia Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
LQDA
15 May 24
(NASDAQ:LQDA), offering a diverse range of perspectives from bullish to bearish.
The table below summarizes their recent ratings, showcasing
Liquidia Corporation Reports First Quarter 2024 Financial Results and Provides Corporate Update
LQDA
13 May 24
) associated with interstitial lung disease (ILD) includes a diverse collection of up to 150 different pulmonary diseases, including interstitial pulmonary
The Analyst Landscape: 5 Takes On Liquidia
LQDA
1 Apr 24
months, revealing a diverse range of perspectives from bullish to bearish.
The table below summarizes their recent ratings, showcasing
Unveiling 6 Analyst Insights On Liquidia
LQDA
13 Mar 24
) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The following table provides a quick overview
Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate Update
LQDA
13 Mar 24
a diverse collection of up to 150 different pulmonary diseases, including interstitial pulmonary fibrosis, chronic hypersensitivity pneumonitis
- Prev
- 1
- Next